Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy
Santiago Mercadal, Kwang Woo Ahn, Mariam Allbee‐Johnson, Siddhartha Ganguly, Praveen Ramakrishnan Geethakumari, Sanghee Hong, Adriana K. Malone, Hemant S. Murthy, Attaphol Pawarode, Alejandro Sica, Melhem Solh, Celalettin Üstün, Mazyar Shadman, Craig S. Sauter, Mehdi Hamadani, Alex F. Herrera, Catherine J. Lee
Topics & Concepts
Chimeric antigen receptorCD19MedicineCentral nervous systemLymphomaPrimary central nervous system lymphomaAntigenImmunologyReceptorTargeted therapyOncologyInternal medicineImmunotherapyCancerImmune systemCAR-T cell therapy research